» Authors » A A KRAMER

A A KRAMER

Explore the profile of A A KRAMER including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 102
Citations 292
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mendez C, Jaffray C, Wong V, Salhab K, KRAMER A, Carey L, et al.
J Surg Res . 2000 Jun; 91(2):165-70. PMID: 10839967
Background: Exposure to sublethal hemorrhage (SLH) makes rats tolerant to subsequent hemorrhagic or septic shock and is associated with altered NF-kappaB activity. The purpose of this study was to explore...
2.
Mendez C, KRAMER A, Salhab K, Valdes G, Norman J, Tracey K, et al.
Ann Surg . 1999 Jun; 229(6):843-9; discussion 849-50. PMID: 10363898
Objective: To determine if cross-tolerance to septic shock could be induced by a previous insult with sublethal hemorrhage (SLH) and to characterize the mechanisms involved in this induced protective response....
3.
KRAMER A, POSTLER G, Salhab K, Mendez C, Carey L, Rabb H
Kidney Int . 1999 Jun; 55(6):2362-7. PMID: 10354283
Background: Despite the advent of dialysis, survival with acute renal failure when associated with multiorgan failure is poor. The development of lung injury after shock or visceral ischemia has been...
4.
KRAMER A, Salhab K, Shafii A, Norman J, Carey L, Mendez C
J Surg Res . 1999 May; 83(2):89-94. PMID: 10329100
Background: Tolerance to hemorrhagic or endotoxic shock can be induced by prior sublethal hemorrhage (SLH). The purpose of this study was to explore whether alterations in signal transduction pathways involving...
5.
Zervos E, KRAMER A, Salhab K, Norman J, Carey L, Rosemurgy A
J Trauma . 1999 Feb; 46(1):145-9. PMID: 9932698
Background: Tolerance to lipopolysaccharide (LPS) induced by previous hemorrhage in mice is associated with a blunted interleukin 1 (IL-1) response, suggesting down-regulation of the cytokine cascade as a possible protective...
6.
Simoes E, Sondheimer H, Top Jr F, Meissner H, Welliver R, KRAMER A, et al.
J Pediatr . 1998 Oct; 133(4):492-9. PMID: 9787686
Objective: To examine the effectiveness of respiratory syncytial virus immune globulin administered intravenously (RSV-IGIV) in reducing hospitalization for treatment of RSV in children with congenital heart disease (CHD). Methods: Children...
7.
Yang J, Denham W, Tracey K, Wang H, KRAMER A, Salhab K, et al.
Shock . 1998 Sep; 10(3):169-75. PMID: 9744644
Macrophage overproduction of inflammatory mediators is detrimental in the progression of acute pancreatitis. Although inhibition of inflammatory mediators has been shown to decrease the severity of experimental pancreatitis and improve...
8.
Rodriguez W, Gruber W, Welliver R, Groothuis J, Simoes E, Meissner H, et al.
Pediatrics . 1997 Mar; 99(3):454-61. PMID: 9041304
Objectives: To evaluate the efficacy of high-titer intravenous respiratory syncytial virus immune globulin (RSVIG) in the treatment of children at high risk for severe RSV infection who were hospitalized with...
9.
Groothuis J, Simoes E, Lehr M, KRAMER A, Hemming V, Rodriguez W, et al.
Antimicrob Agents Chemother . 1995 Mar; 39(3):668-71. PMID: 7793870
Respiratory syncytial virus (RSV) causes serious illness (lower respiratory illness) in preterm infants. RSV antibody-enriched immunoglobulin (RSVIG) that was lyophilized (LYO) protected against RSV lower respiratory illness. The Food and...
10.
Boppana S, Polis M, KRAMER A, Britt W, Koenig S
J Infect Dis . 1995 Jan; 171(1):182-5. PMID: 7798660
Human cytomegalovirus (HCMV) causes retinitis and is the leading cause of blindness in patients infected with the human immunodeficiency virus (HIV). While most patients with HIV are HCMV seropositive, not...